PuSH - Publication Server of Helmholtz Zentrum München

Yankova, E.* ; Blackaby, W.* ; Albertella, M.* ; Rak, J.* ; De Braekeleer, E.* ; Tsagkogeorga, G.* ; Pilka, E.S.* ; Aspris, D.* ; Leggate, D.* ; Hendrick, A.G.* ; Webster, N.A.* ; Andrews, B.* ; Fosbeary, R.* ; Guest, P.* ; Irigoyen, N.* ; Eleftheriou, M.* ; Gozdecka, M.* ; Dias, J.M.L.* ; Bannister, A.J.* ; Vick, B. ; Jeremias, I. ; Vassiliou, G.S.* ; Rausch, O.* ; Tzelepis, K.* ; Kouzarides, T.*

Small molecule inhibition of METTL3 as a strategy against myeloid leukaemia.

Nature 593, 597-601 (2021)
Postprint DOI PMC
Open Access Green
The N6-methyladenosine (m6A) is an abundant internal RNA modification1,2 catalysed predominantly by the METTL3-METTL14 methyltransferase complex3,4. The m6A writer METTL3 has been linked to the initiation and maintenance of acute myeloid leukaemia (AML), but its true therapeutic importance is still unknown5-7. Here we present the identification and characterization of a highly potent and selective first-in-class catalytic inhibitor of METTL3 (STM2457) and its co-crystal structure bound to METTL3/METTL14. Treatment with STM2457 leads to reduced AML growth, and an increase in differentiation and apoptosis. These cellular effects are accompanied by selective reduction of m6A levels on known leukaemogenic mRNAs and a decrease in their expression consistent with a translational defect. We demonstrate that pharmacological inhibition of METTL3 in vivo leads to impaired engraftment and prolonged survival in various AML mouse models, specifically targeting key stem-cell subpopulations of AML. Collectively, these results reveal the inhibition of METTL3 as a potential therapeutic strategy against AML, and provide proof of concept that the targeting of RNA modifying enzymes represents a promising new avenue for anti-cancer therapy.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Mettl3-mettl14 Complex; Rna; N-6-methyladenosine; Chromatin; Methyltransferase; Differentiation; Translation; Demethylase; Refinement; Promoter
ISSN (print) / ISBN 0028-0836
e-ISSN 1476-4687
Journal Nature
Quellenangaben Volume: 593, Issue: 7860, Pages: 597-601 Article Number: , Supplement: ,
Publisher Nature Publishing Group
Publishing Place London
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
Grants Cancer Research UK Senior Cancer Fellowship
ERC
Wellcome Trust
Kay Kendall Leukaemia Fund project grant
Leukaemia UK
Cambridge-LMU Strategic Partnership Award
Cancer Research UK